These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 2938321)

  • 21. The correlation of tissue typing, mixed lymphocyte culture, and related donor renal allograft survival.
    Cerilli J; Newhouse YG; Williams MA
    Transplant Proc; 1978 Dec; 10(4):953-4. PubMed ID: 153622
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cadaveric kidney transplantation and HLA typing in Switzerland 1977-1981. Combined analysis of Swisstransplant and EDTA Registry].
    Schweiz Med Wochenschr; 1984 Dec; 114(52):1951-4. PubMed ID: 6395329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal transplantation in Australia and New Zealand, 1963-1982: report from the ANZ Data Registry.
    Disney A
    Transplant Proc; 1984 Aug; 16(4):973-8. PubMed ID: 6380061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated DR mismatching need not be hazardous to kidney graft survival.
    Salmela K; Eklund B; Höckerstedt K; Isoniemi H; Koskimies S; von Willebrand E; Ahonen J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):677-8. PubMed ID: 2650219
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of HLA matching in cadaver renal transplants.
    Najarian JS; Migliori RJ; Simmons RL; Ascher NL; Payne WD; Dunn D; Sutherland DE; Fryd DS
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):249-56. PubMed ID: 3291251
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation.
    Bryan CF; Harrell K; Aeder MI; Luger AM; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA
    Transplant Proc; 1993 Dec; 25(6):3060-3. PubMed ID: 8266452
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of clinical response of DR-matched, MLC-compatible cadaver renal allografts and those from HLA-identical related donors.
    Conti DJ; Andersen R; Soper WD; Wolf JS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):652-4. PubMed ID: 2978928
    [No Abstract]   [Full Text] [Related]  

  • 29. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DR typing in cadaver kidney donors and recipients in Copenhagen.
    Thomsen M; Astrup L; Jakobsen B; Morling N; Platz P; Ryder LP; Svejgaard A; Løkkegaard H; Ladefoged J; Thaysen JH
    Scand J Urol Nephrol Suppl; 1981; 64():79-86. PubMed ID: 6815796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
    Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA matching and cyclosporin immunosuppression: a strong correlation.
    Cicciarelli J; Terasaki PI; Mickey MR
    Lancet; 1986 Feb; 1(8475):267. PubMed ID: 2868272
    [No Abstract]   [Full Text] [Related]  

  • 34. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 35. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 36. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mixed lymphocyte culture as a compatibility test for bone marrow transplantation].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1986 Jan; 98(2):44-9. PubMed ID: 2938340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
    Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
    Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cyclosporine immunosuppression in humans.
    Kerman RH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):143-52. PubMed ID: 3284064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.